+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Typhoid Fever Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767936
  • Report
  • April 2019
  • Region: Global
  • 62 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Bharat Biotech Ltd
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • Novartis AG
  • Prokarium Ltd
  • Syneos Health Inc
  • MORE
The global clinical trial report- “2019 Typhoid Fever Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Typhoid Fever. It presents in-depth analysis of Typhoid Fever clinical trials across markets and companies. The research work is for providing complete understanding into trends in Typhoid Fever.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Typhoid Fever clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Typhoid Fever

The research work is prepared through extensive and continuous research on Typhoid Fever trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Typhoid Fever patients are identified
  • The report includes panorama of Typhoid Fever clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Typhoid Fever clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Bharat Biotech Ltd
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • Novartis AG
  • Prokarium Ltd
  • Syneos Health Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Typhoid Fever Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Typhoid Fever Clinical Trials by Region
2.2.2 Average Enrollment of Typhoid Fever Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Typhoid Fever Treatment, 2019

3. Region wise Typhoid Fever Clinical Trials
3.1 Asia Pacific Typhoid Fever Clinical Trials by Country
3.2 Europe Typhoid Fever Clinical Trials by Country
3.3 North America Typhoid Fever Clinical Trials by Country
3.4 Middle East and Africa Typhoid Fever Clinical Trials by Country
3.5 South and Central America Typhoid Fever Clinical Trials by Country

4. Typhoid Fever Clinical Trial Trends
4.1 Start Year wise Typhoid Fever Clinical Trials
4.2 Phase wise Typhoid Fever Clinical Trials
4.3 Trial Status wise Typhoid Fever Clinical Trials
4.4 Trial Type wise Typhoid Fever Clinical Trials

5. Typhoid Fever Average Enrollment Trends
5.1 Average Enrollment in Typhoid Fever Trials by Year
5.2 Average Enrollment in Typhoid Fever Trials by Phase
5.3 Average Enrollment in Typhoid Fever Trials by Status
5.4 Average Enrollment in Typhoid Fever Trials by Type of Trial

6. Companies Participating in Typhoid Fever Clinical Trials
6.1 Typhoid Fever Trials by Sponsor Type
6.2 Typhoid Fever Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Typhoid Fever Trials- Phase 1
7.2 Typhoid Fever Trials- Phase 2
7.3 Typhoid Fever Trials- Phase 3
7.4 Typhoid Fever Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Typhoid Fever Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Typhoid Fever Clinical Trials and Enrolment
Figure 5: Europe - Country wise Typhoid Fever Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Typhoid Fever Clinical Trials and Enrolment
Figure 7: North America - Country wise Typhoid Fever Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Typhoid Fever Clinical Trials and Enrolment
Figure 9: Typhoid Fever Clinical Trials by Phase
Figure 10: Typhoid Fever Clinical Trials by Trial Status
Figure 11: Typhoid Fever Clinical Trials by Type
Figure 12: Typhoid Fever Clinical Trials by Sponsor Type
Figure 13: Typhoid Fever Clinical Trials by Leading Sponsors
Figure 14: Typhoid Fever Average Enrollment by Phase
Figure 15: Typhoid Fever Average Enrollment by Trial Status
Figure 16: Typhoid Fever Average Enrollment by Type
Figure 17: Typhoid Fever- Average Enrolment by Type of Sponsors
Figure 18: Typhoid Fever- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Typhoid Fever Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Typhoid Fever Clinical Trials and Enrolment
Table 5: Europe - Country wise Typhoid Fever Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Typhoid Fever Clinical Trials and Enrolment
Table 7: North America - Country wise Typhoid Fever Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Typhoid Fever Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Typhoid Fever Average Enrollment by Phase
Table 15: Typhoid Fever Average Enrollment by Trial Status
Table 16: Typhoid Fever Average Enrollment by Type
Table 17: Typhoid Fever- Average Enrolment by Type of Sponsors
Table 18: Typhoid Fever- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Bharat Biotech Ltd
  • Emergent BioSolutions Inc
  • GlaxoSmithKline Plc
  • Harbin Pharmaceutical Group Co Ltd
  • Jilin Wantong Pharmacy Group Co Ltd
  • Novartis AG
  • Prokarium Ltd
  • Syneos Health Inc
  • Wellcome Trust
  • Yifan Pharmaceutical Co.,Ltd
Note: Product cover images may vary from those shown
Adroll
adroll